More risks emerge for alemtuzumab in MS on: April 08, 2018, 04:27:28 pm #1 From MedPage Today, "More risks emerge for alemtuzumab in MS" (April 6, 2018): More Risks Emerge for Alemtuzumab in MS Reports of gallbladder, immunodeficiency, cardiac problems trickle in medpagetoday.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
